| Â | HPV L1(+) | Â | Â |
|---|
Region | Unclassified No. (%) | Single infection No. (%) | Multiple infection No. (%) |
P
| Total No. (%) | HPV L1 (-) No. (%) |
P
|
|---|
Anyang (N = 166) | 20(23.3) | 57(66.3) | 9(10.5) | 0.963†| 86(51.8) | 80(48.2) | 0.131‡ |
Shantou (N = 103) | 4(6.5) | 43(69.4) | 15(24.2) | Â | 62(60.2) | 41(39.8) | Â |
Xinjiang (N = 78) | 6(14.3) | 30(71.4) | 6(14.3) | Â | 42(53.8) | 36(46.2) | Â |
China (N = 347) | 30(15.8) | 130(68.4) | 30(15.8) | 0.834††| 190(54.8) | 157(45.2) | 0.522‡‡ |
US (N = 88) | 1(1.9) | 40(74.1) | 13(24.1) | Â | 54(61.4) | 34(38.6) | Â |
Total (N = 435) | 31(12.7) | 170(69.7) | 43(17.6) | Â | 244(56.1) | 191(43.9) | Â |
- *Multiple infection was determined by type specific E6 or E7 PCR.
- †P value for the rates of multiple type infections among three areas of China was calculated by unconditional logistic regression adjusted for age, gender, tobacco, alcohol and pathological stage.
- ††P value for the rates of multiple type infections between China and US was calculated by unconditional logistic regression adjusted for age, gender, tobacco, alcohol and pathological stage.
- ‡P value for HPV detection rates among three areas of China was calculated by unconditional logistic regression adjusted for age, gender, tobacco, alcohol and pathological stage.
- ‡‡P value for HPV detection rates between China and US was calculated by unconditional logistic regression adjusted for age, gender, tobacco, alcohol and pathological stage.
